Skip To Main Content
Deze website is alleen bedoeld voor zorgverleners van België en Luxemburg.
Campus
  • Wetenschap
  • Vaccins
  • Artikelen
  • Opleiding
Campus
  • Wetenschap
  • Vaccins
  • Artikelen
  • Opleiding

Sanofi's betrokkenheid in cutaan plaveiselcel carcinoom

Van eind 2018 tot heden bood Sanofi nieuw perspectief in het leven van meer dan 200 patiënten die lijden aan gevorderd cutaan plaveiselcelcarcinoom (CSCC) via zijn early access program.

Ontdek Sanofi’s betrokkenheid in deze video.

Gerelateerde ziekte

Huidkanker

Gerelateerde paginas
Underneath the skin

Underneath the Skin: Hidden Challenges of Uncontrolled AD and PN

What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?

Leer meer
Advancing the treatment: Meeting the challenge of uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

Advancing Treatment for Uncontrolled AD and PN: New Approaches

As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.

Leer meer
Lipid management in patients with diabetes mellitus

Lipid management in patients with diabetes mellitus

Key principles of lipid management (LDL-C in particular) in accordance with the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, and the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.

Leer meer
Sanofi Belgium - MAT-BE-2100417 – 06/2021